Selective increase of Nurr1 mRNA expression in mesencephalic dopaminergic neurons of D2 dopamine receptor-deficient mice. 2000

K Y Tseng, and C Roubert, and L Do, and M Rubinstein, and M A Kelly, and D K Grandy, and M J Low, and O S Gershanik, and M G Murer, and B Giros, and R Raisman-Vozari
Departamento de FisiologĂ­a y BiofĂ­sica, Facultad de Medicina, Universidad de Buenos Aires, Argentina.

The orphan nuclear receptor Nurr1 is critical for the survival of mesencephalic dopaminergic precursor neurons. Little is known about the mechanisms that regulate Nurr1 expression in vivo. Other members of this receptor family have been shown to be activated by dopamine. We sought to determine if Nurr1 expression is also regulated by endogenous dopamine through dopamine receptors. Consequently, we investigated the expression of Nurr1 mRNA in genetically modified mice lacking both functional copies of the D2 dopamine receptor gene and in their congenic siblings. Quantitative in situ hybridization demonstrated a significant increased expression of Nurr1 mRNA in the substantia nigra pars compacta and the ventral tegmental area of D2 dopamine receptor -/- mice. No change in Nurr1 expression was detected in other brain regions, such as the habenular nuclei and temporal cortex. Among the cell groups studied, mesencephalic dopaminergic neurons are unique in that they express both Nurr1 and the D2 dopamine receptor, and synthesize dopamine. Thus, it seems plausible that the selective increase in Nurr1 expression observed in D2 receptor-deficient mice is the consequence of an impaired dopamine autoreceptor function.

UI MeSH Term Description Entries
D008636 Mesencephalon The middle of the three primitive cerebral vesicles of the embryonic brain. Without further subdivision, midbrain develops into a short, constricted portion connecting the PONS and the DIENCEPHALON. Midbrain contains two major parts, the dorsal TECTUM MESENCEPHALI and the ventral TEGMENTUM MESENCEPHALI, housing components of auditory, visual, and other sensorimoter systems. Midbrain,Mesencephalons,Midbrains
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D013378 Substantia Nigra The black substance in the ventral midbrain or the nucleus of cells containing the black substance. These cells produce DOPAMINE, an important neurotransmitter in regulation of the sensorimotor system and mood. The dark colored MELANIN is a by-product of dopamine synthesis. Nigra, Substantia,Nigras, Substantia,Substantia Nigras
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription
D017403 In Situ Hybridization A technique that localizes specific nucleic acid sequences within intact chromosomes, eukaryotic cells, or bacterial cells through the use of specific nucleic acid-labeled probes. Hybridization in Situ,Hybridization, In Situ,Hybridizations, In Situ,In Situ Hybridizations
D017448 Receptors, Dopamine D2 A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D2-class receptor genes contain INTRONS, and the receptors inhibit ADENYLYL CYCLASES. Dopamine D2 Receptors,Dopamine-D2 Receptor,D2 Receptors, Dopamine,Dopamine D2 Receptor,Receptor, Dopamine-D2

Related Publications

K Y Tseng, and C Roubert, and L Do, and M Rubinstein, and M A Kelly, and D K Grandy, and M J Low, and O S Gershanik, and M G Murer, and B Giros, and R Raisman-Vozari
October 1999, Experimental neurology,
K Y Tseng, and C Roubert, and L Do, and M Rubinstein, and M A Kelly, and D K Grandy, and M J Low, and O S Gershanik, and M G Murer, and B Giros, and R Raisman-Vozari
July 1997, Neuroscience,
K Y Tseng, and C Roubert, and L Do, and M Rubinstein, and M A Kelly, and D K Grandy, and M J Low, and O S Gershanik, and M G Murer, and B Giros, and R Raisman-Vozari
March 2004, Journal of neurochemistry,
K Y Tseng, and C Roubert, and L Do, and M Rubinstein, and M A Kelly, and D K Grandy, and M J Low, and O S Gershanik, and M G Murer, and B Giros, and R Raisman-Vozari
July 1991, Brain research. Molecular brain research,
K Y Tseng, and C Roubert, and L Do, and M Rubinstein, and M A Kelly, and D K Grandy, and M J Low, and O S Gershanik, and M G Murer, and B Giros, and R Raisman-Vozari
November 2002, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
K Y Tseng, and C Roubert, and L Do, and M Rubinstein, and M A Kelly, and D K Grandy, and M J Low, and O S Gershanik, and M G Murer, and B Giros, and R Raisman-Vozari
January 2002, Brain research. Developmental brain research,
K Y Tseng, and C Roubert, and L Do, and M Rubinstein, and M A Kelly, and D K Grandy, and M J Low, and O S Gershanik, and M G Murer, and B Giros, and R Raisman-Vozari
April 2006, The Journal of neuroscience : the official journal of the Society for Neuroscience,
K Y Tseng, and C Roubert, and L Do, and M Rubinstein, and M A Kelly, and D K Grandy, and M J Low, and O S Gershanik, and M G Murer, and B Giros, and R Raisman-Vozari
April 2014, Journal of biomedical science,
K Y Tseng, and C Roubert, and L Do, and M Rubinstein, and M A Kelly, and D K Grandy, and M J Low, and O S Gershanik, and M G Murer, and B Giros, and R Raisman-Vozari
April 1997, Science (New York, N.Y.),
K Y Tseng, and C Roubert, and L Do, and M Rubinstein, and M A Kelly, and D K Grandy, and M J Low, and O S Gershanik, and M G Murer, and B Giros, and R Raisman-Vozari
October 2008, The European journal of neuroscience,
Copied contents to your clipboard!